EcoDrugPlus

Ribosomal Protein L39

Ensembl ID : ENSKMAG00000020282
Gene Symbol: RPL39
3 Cross references
331 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSKMAG00000019520
Gene Symbol: RPL4
3 Cross references
341 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSKMAG00000002090
Gene Symbol: RPL5
4 Cross references
469 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSKMAG00000003779
Gene Symbol: RPL6
3 Cross references
486 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSKMAG00000006918
Gene Symbol: RPL7
3 Cross references
492 Possible Orthologues:

Ribosomal Protein L7a

Ensembl ID : ENSKMAG00000009779
Gene Symbol: RPL7A
4 Cross references
370 Possible Orthologues:

Ribosomal Protein L8

Ensembl ID : ENSKMAG00000005087
Gene Symbol: RPL8
3 Cross references
276 Possible Orthologues:

Ribosomal Protein L9

Ensembl ID : ENSKMAG00000000063
Gene Symbol: RPL9
3 Cross references
509 Possible Orthologues:

Ribosomal Protein S10

Ensembl ID : ENSKMAG00000016280
Gene Symbol: RPS10
3 Cross references
379 Possible Orthologues:

Ribosomal Protein S11

Ensembl ID : ENSKMAG00000018535
Gene Symbol: RPS11
3 Cross references
285 Possible Orthologues:

Ribosomal Protein S12

Ensembl ID : ENSKMAG00000012558
Gene Symbol: RPS12
3 Cross references
392 Possible Orthologues:

Ribosomal Protein S13

Ensembl ID : ENSKMAG00000005963
Gene Symbol: RPS13
3 Cross references
377 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).